Resources

Only a third of the nearly 65 million Americans at risk for heart disease are taking aspirin.

Babies born to mothers who have diabetes have a significantly increased risk of cardiovascular malformations, according to recent British report.

Recent clinical trials and guidelines suggest that patients with diabetes should be treated with multiple antihypertensives to achieve blood pressure target goals in order to reduce risk of cardiovascular disease.

The age at which infants are introduced to cereal foods may affect their risk of developing childhood, or type 1, diabetes. Waiting until the age of 3 to introduce solid foods is recommended.

Insulin therapy improves exercise ventilatory efficiency and oxygen uptake in heart failure patients with type 2 diabetes, new research by Italian investigators suggests.

In addition to improving insulin sensitivity, pioglitazone treatment improves endothelial function in conduit arteries and decreases plasma levels of C-reactive protein.

New research indicates that a nonremovable cast helps diabetic foot sores heal faster than special shoes that are typically used.

A dual therapy regiment of pravastatin and captopril appears to improve lipid and glucose metabolism while decreasing blood pressure.

New research suggests that the electrocardiogram may not be an accurate guide if the patient is taking drugs called sulfonylureas for diabetes.

The FDA has released the following information. Glucophage XR tablets (metformin HCl extended release), 500 mg, 100 count bottles, Rx only, Distributed by: Bristol-Myers Squibb CompanyRecall # D-337-3. See Item #2